Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

NCT00014443 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: thalidomide
DRUG: topotecan hydrochloride

Sponsor

Rush University Medical Center